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Objectives: Considering the controversial results regarding the relationship between vitamin
D  levels and bone mineral density in different populations, the present study was designed
to  evaluate this correlation in a healthy Iranian population.
Methods: Using a random cluster sample of apparently healthy men  and women, this multi-
center cross-sectional study was carried out among 4450 individuals living in urban areas of
ﬁve  major cities in Iran. Bone mineral density (BMD) values at different sites were analyzed
along with the serum levels of 25(OH)D and PTH. Analysis of variance (ANOVA) was used to
estimate the main effects, through comparing the mean values of these markers based on
the  bone mineral density status of the study group in each sex.
Results: 25(OH)D levels were inversely correlated with BMD values at total hip (r = −0.062 in
men  and r = −0.057 in women) and spine (r = −0.076 in men and r = −0.107 in women). After
adjusting the data for age, the inverse correlation was no longer statistically signiﬁcant.
Conclusion: Serum 25(OH)D levels are inversely correlated with bone mass values in both
sexes.
©  2015 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Correlac¸ão  entre  os  níveis  de  vitamina  D  e  densidade  mineral  óssea  em
uma  populac¸ão  iraniana  saudável
r  e  s  u  m  oPalavras chave:
Densidade mineral óssea
Osteoporose
Objetivos: Considerando os resultados controversos sobre a relac¸ão entre níveis de vitamina
D  e densidade mineral óssea em diferentes populac¸ões, o presente estudo foi desenhado
para avaliar esta correlac¸ão em uma populac¸ão iraniana saudável.
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Métodos: Usando uma amostra aleatória de homens e mulheres aparentemente saudáveis,
este  estudo transversal multicêntrico considerou 4450 indivíduos que vivem em na região
urbana de cinco grandes cidades no Irã. Os valores da densidade mineral óssea (DMO)
foram analisados em conjunto com os níveis séricos de 25(OH)D e PTH. Análise da variac¸ão
(ANOVA) foi utilizada para estimar os principais efeitos através da comparac¸ão entre os val-
ores  médios destes marcadores e a condic¸ão da densidade mineral óssea de cada gênero
nesta amostra de estudo.
Resultados: Níveis de 25(OH)D foram inversamente proporcionais aos valores de DMO a nível
do  quadril (r = -0.062 em homens e r = -0.057 em mulheres) e coluna vertebral (r = -0.076 em
homens e r = -0.107 em mulheres). Após ajuste dos dados para idade, a correlac¸ão negativa
não foi mais estatisticamente signiﬁcante.
Conclusão: Níveis séricos de 25(OH)D são inversamente correlacionados com os valores de
massa óssea em ambos os gêneros.
© 2015 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://
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(ntroduction
steoporosis is a systemic disease characterized by low bone
ass and microarchitectural deterioration of bone tissue,
esulting in an increased risk of fracture; if identiﬁed early in
ts course, however, many  of the fractures can be prevented.1
Apart from modiﬁable lifestyle factors, bone mineral den-
ity (BMD) is inﬂuenced by several genetic, environmental, and
ormonal factors.2,3 While the inﬂuence of biochemical mark-
rs on the fracture risk has been well documented in previous
tudies, the association between serum 25(OH)D levels and
MD  in different ethnicities residing in different geographic
reas remains controversial. Many  of them have reported no
irect relationship between serum 25(OH)D levels and BMD
as observed.4
The present study therefore was designed to evaluate the
elationship between vitamin D status, bone mineral density
nd PTH in a healthy Iranian population.
aterials  and  methods
ubject  selection
his study is part of a comprehensive survey (IMOS) assessing
he prevalence of osteoporosis and related factors among
ealthy adults (age range: 20–70 Years), representative sample
f Iranian population living in urban areas, in the urban areas
f ﬁve major cities of Iran (Tehran, Tabriz, Mashhad, Shiraz
nd Booshehr) in late winter 2001 (February–March).
Details on the survey design and methods have been
eported previously.5 Brieﬂy, the IMOS used a random cluster
ampling design to draw ﬁve provincially representative, inde-
endent samples of healthy adults excluding those taking
edications that could modify bone metabolism, those with
epatic or renal disorders, metabolic bone disease, hypercor-
isolism, malabsorption, sterility, oligomenorrhea, diabetes,
alignancy, and immobility for more  than 1 week as well
s the pregnant and lactating women. The Research Ethics
ommittee of the Endocrine and Metabolism Research Center
EMRC) approved the protocol of this study. An informedcreativecommons.org/licenses/by-nc-nd/4.0/).
consent was obtained from the subjects before they entered
the study.
All subjects underwent a detailed medical examination,
measurement of bone mineral density at different sites, and
certain biochemical testing. Apart from demographic data,
the subjects were asked about their menopausal status and
the years passed since their menopause. Menopause, in this
study, was deﬁned as previous natural or surgical cessation of
menstruation for more  than 12 months.
Biochemical  tests
A fasting blood sample (10 cm3 of venous blood) was taken
from all participants at their residence place. Sample cen-
trifuge and serum extraction were done in the ﬁeld. The
samples were then frozen and sent to the EMRC laboratory
for further analysis.
Serum Ca and P levels were analyzed by a calorimetric
method using Chem. Enzyme Lab Kit; Iran. The normal labo-
ratory range for serum Ca was 8.6–10.8 mg/dl and for serum
P was 2.3 to 5 mg/dl. Serum levels of vitamin D (25 (OH)
D) and PTH were measured with RIA (Radio-Immuno-Assay)
method (IDS Ltd Kit; UK) and IRMA (Immuno-Radiometric)
method (Diasorin Kit; USA), respectively. Normal range for
serum 25(OH)D and PTH were 23–113 ng/ml and 13–54 pg/ml,
correspondingly. The inter- and intra-assay variations for the
markers were 8%/6.8% and 8.9%/6.1%, respectively.
Based on 25(OH)D values, subjects were classiﬁed as those
suffering from vitamin D deﬁciency (≤20 ng/ml), – insufﬁ-
ciency (mild deﬁciency) (20–30 ng/ml) and – sufﬁciency (higher
than 30 ng/ml). The complete method used to determine the
25(OH)D levels for classifying the participants is described in
our previous studies.6,7
Bone  mineral  density
In each city, patients underwent an L1–L4 anteroposterior lum-
bar spine, hip and its sub-regions DXA study with a Lunar
DPXMD densitometer (Lunar 7164, GE, Madison, WI)  equipped
with NHANES III dataset by a trained operator according to the
manufacturer’s instruction. Results were expressed as T- and
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Z-scores. Quality control procedures were carried out in accor-
dance with the manufacturer’s recommendations. In each
city, the instrument variation was determined regularly by a
weekly calibration procedure using a phantom supplied by the
manufacturer (the phantom equilibrium was sent from one
city to another after each testing). The interdevice variance
was checked several times during the study period. There was
an irrelevant small difference between the reported measures
which was negligible. Precision error for BMD  measurements
was 1–1.5% in the lumbar and 2–3% in the femoral regions.
Based on World Health Organization Study Group recom-
mendation, BMD  values were classiﬁed as normal, osteopenic
and osteoporotic.8 Since, there is no widely accepted deﬁnition
of osteoporosis in males, the WHO  criteria for testing osteo-
porosis in the female population was similarly used for this
group.
Statistical  analysis
Data were entered to Microsoft Access Databank. In view of the
fact that a different instrument was used to assess the BMD
in subjects who were recruited in Booshehr; data gathered in
this city was assumed to be missing. All statistical analyses
were performed with SPSS 13.0 for Windows (SPSS, Chicago,
IL) based on a pair-wise approach, and P values lower than 0.05
were considered statistically signiﬁcant.
All analyses were conducted separately for each gen-
der, and then for the group overall. Means ± SD were used
to express standard descriptive statistics. Categorical vari-
ables were expressed as percentages and compared using
Chi-square. Differences among means were investigated by
analysis of variance (ANOVA) with post hoc test. The two-sided
Student’s t-test was used to compare the mean biochemi-
cal values in different groups. The association between the
outcome variable (BMD) and the biochemical variables was
examined by bivariate analysis and then by adjusted stepwise
multiple regression analyses.
Results
A total of 4450 individuals with the mean age of 42.6 ± 13.9
years were studied; from among them 1900 (42.7%) were
male. Overally some 246 (6.5%) of the total studied sub-
jects (4.8% of males and 7.7% of females) were reported to
have osteoporosis. There was a signiﬁcant difference between
the frequencies of osteoporosis among the two genders (P-
value < 0.001). Osteopenia, on the other hand, was reported
among 848 (58.6%) of the studied females and some 600 (41.4%)
of the studied men.
Serum levels of 25(OH)D was signiﬁcantly higher among
those suffering from osteoporosis (Table 1). The Pearson’s cor-
relation coefﬁcients between the study variables revealed an
inverse correlation between 25(OH)D levels and BMD values at
total hip (r = −0.062 in men  and r = −0.057 in women) and spine
(r = −0.076 in men  and r = −0.107 in women) (Table 2).The correlation between PTH levels and BMD  values at
all sites failed to remain signiﬁcant after adjusting data for
gender. Each year increase in age was associated with 1.061
and 1.141 higher risk of developing osteoporosis in males and1 6;5 1(4):454–458
females, respectively. After adjusting the data for age, the
inverse correlation between age, and 25(OH)D levels and BMD
values at all sites was no longer statistically signiﬁcant (data
not shown).
Discussion
Hypovitaminosis D and osteoporosis is frequent in individuals
living in countries with abundant sunshine such as Iran.9–12
The reason behind this ﬁnding, however, remains unclear.
Many believe the optimal level of 25(OH)D, which leads to
maximum suppression of circulating iPTH levels, should be
deﬁned based on functional rather than an epidemiological
deﬁnition.13
Considering the correlation between serum 25(OH)D levels
and BMD values controversial results are found. While cer-
tain studies have failed to report any correlations between
these two variables, others have revealed a positive associ-
ation between serum 25(OH)D levels and BMD  values.4,14–18
Arya et al. reported a signiﬁcant correlation between serum
25(OH)D levels and BMD  values at proximal femur.11 They
concluded that subclinical 25(OH)D deﬁciency has an adverse
effect on bone mass and therefore is linked with low BMD  in
these subjects. Villareal et al. similarly suggested that women
with low serum 25(OH)D levels should be referred for osteo-
porosis screening, stressing that low BMD could be the only
symptom in these women.19
On the contrary with these studies, the present research
demonstrated a signiﬁcant but negative relation between
25(OH)D levels and BMD values at all the studied sites.
Apparent discrepancies between our study and previous
ones can be contributed to the fact that many of these
population-based studies have recruited subjects with a rel-
atively good health status, and therefore lower prevalence of
severe vitamin D deﬁciency and osteoporosis.14 The probable
association between 25(OH)D and BMD  may also vary based on
the various sites used for densitometry measurement owing
to different composition of trabecular and cortical bone tis-
sue. Moreover, sampling from a population-based study, and
comparatively lower prevalence of severe vitamin D deﬁciency
might increase the generalizability of our results. In addition,
the higher serum levels of 25(OH)D in osteoporotic patients
could be secondary to the fact that osteoporosis is more  com-
mon  among the elderly and this age group are more  frequently
treated with Vitamin D supplements. Considering our exclu-
sion criteria, individuals taking such supplements should not
have been recruited in the present study; this comes while
many people, particularly, older individuals, have received the
supplements without being aware of their name.
The mean serum 25(OH)D concentration of the whole study
population was 35.37 ± 30.3 ng/ml and some 67.2% of the stud-
ied subjects were reported to have moderate to severe vitamin
D deﬁciency regardless of their gender. Except for trochanter,
there was no difference in the correlation between these vari-
ables in the two genders. It should be noted that the higher
vitamin D levels reported in osteoporotic cases in this study
could be contributed to the lower number of studied osteo-
porotic cases compared to that of normal cases. Moreover,
considering the subgroup analysis and the fact that the retired
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Table 1 – The mean values of the studied biochemical markers based on bone mineral density categorization.
Bone mineral density categorization (no. of cases) P value
Osteoporosis (246) Osteopenia (1448) Normal (2096)
25(OH)D (ng/ml) 42.03 ± 34.59 35.97 ± 26.49 33.04 ± 23.78 <0.001
PTH (pg/ml) 28.12 ± 16.19 28.82 ± 16.18 28.73 ± 17.72 0.856
Ca (mg/dl) 9.44 ± 0.54 9.43 ± 0.56 9.46 ± 0.57 0.454
P (mg/dl) 3.22 ± 0.49 3.15 ± 0.48 3.19 ± 0.47 0.109
Data expressed as mean ± SD.
Table 2 – The partial correlation between biochemical markers and BMD  values after controlling for gender (A – male and
B – female).
25(OH)D PTH Ca P BMD (femoral neck) BMD (trochanter) BMD (total hip)
A - Male:
PTH −0.101a
Ca 0.053b −0.032a
P 0.077a 0.088a 0.213a
BMD (femoral neck) −0.073a 0.023 0.070a 0.137a
BMD (Trochanter) 0.000 −0.008 0.044 0.074b 0.770a
BMD (total Hip) −0.062b 0.013 0.064b 0.090a 0.876a 0.934a
BMD (spine) −0.076a 0.038 0.022 0.083a 0.633a 0.616a 0.666a
B - Female:
PTH −0.175a
Ca 0.079a −0.038
P 0.075a −0.072a 0.245a
BMD (femoral neck) −0.095a −0.024 0.004 0.004
BMD (Trochanter) −0.074a −0.046 −0.037 −0.054b 0.806a
BMD (total Hip) −0.057b −0.042 −0.021 −0.034 0.889a 0.926a
BMD (spine) −0.107a −0.009 −0.030 −0.053b 0.699a 0.624a 0.689a
a Correlation is signiﬁcant at the 0.01 level (2-tailed).
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ab Correlation is signiﬁcant at the 0.05 level (2-tailed).
nd elderly population in Iran spends more  time outdoors, it
ould be concluded that they are exposed to more  sun and
herefore have higher 25(OH)D levels.
Certain studies have revealed an inverse correlation
etween serum PTH levels and BMD  values, particularly at the
emoral neck, pointing out the catabolic role of PTH on corti-
al bones.15,20 These studies have also shown that decreased
evels of serum calcium are associated with defects in min-
ralization and consequently low BMD.13 In line with these
tudies, Hosseinpanah et al. reported a negative correlation
etween PTH levels and BMD  values at femoral neck in the
bsence of similar correlations between serum 25(OH)D and
MD  of other sites.21 Sadat Ali et al.22 showed that vitamin D
evels signiﬁcantly inﬂuence BMD  reading among Saudi indi-
iduals, pointing out a signiﬁcant positive correlation between
5OHD level and BMD  and signiﬁcant negative correlation with
arathyroid hormone in the studied groups. The present study,
n the contrary, reported PTH to be inversely correlated with
MD  values at all sites rather than spine. The correlation,
owever, was reported to be signiﬁcant only at the femoral
rochanter.
The present study was conducted on healthy individ-
als based on their self-reported history; a potential bias of
ndiagnosed underlying diseases, therefore, is probable. Addi-
ionally, the cross-sectional nature of the present study is
n important limitation of this study. Moreover, this studyonly measured ﬁve biochemical markers, namely PTH and
25(OH)D, while more  recent studies have linked markers such
as intact osteocalcin (OC) to BMD  values and fracture risk.23,24
In addition, 25(OH)D measurements were performed in winter,
when its levels are believed to be at the lowest level com-
pared to other months of the year. It should be noted that the
present study was an observational study in which the effect of
important factors such as population differences (gender, age,
ethnic, sex, extent of sun exposure, and vitamin D intake) was
not assessed. Large prospective studies, therefore, are needed
to better evaluate the correlation between biochemical mark-
ers and BMD values in different populations.
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